Trisalus Life SciencesTLSI
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 34 institutions reported holding Trisalus Life Sciences Inc. (TLSI) in their 13F filings, up 6 from Q4 2024. 12 opened new positions and 5 sold out. The largest holders were Gilder Gagnon Howe & Co. LLC ($4.6M), Wealthcare Advisory Partners LLC ($3.6M) and Vanguard Group Inc. ($2.7M). 3 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Trisalus Life Sciences Inc.
- CUSIP
- 89680M101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $679K |
| Exits | 5 | $2.2M |
All 13F filers, Q4 2024 → Q1 2025: 1,045,188 shares bought and 439,444 shares sold, net +605,744 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 34 holders
| Gilder Gagnon Howe & Co. LLC | 0.06% | Add +5637.6% | 827,357 | $4.6M |
| Wealthcare Advisory Partners LLC | 0.10% | No change | 643,740 | $3.6M |
| Vanguard Group Inc. | 0.00% | Add +2.2% | 486,618 | $2.7M |
| Geode Capital Management, LLC | 0.00% | Add +7.5% | 219,424 | $1.2M |
| Bank of America Corp. | 0.00% | Add +4.0% | 185,532 | $1.0M |
| Millennium Management | 0.00% | Add +65.6% | 133,380 | $736K |
| Bridgeway Capital Management, LLC | 0.01% | No change | 65,000 | $359K |
| MSD Partners, L.P. | 0.16% | No change | 39,999 | $221K |
| Northern Trust Corp. | 0.00% | Add +24.3% | 39,926 | $220K |
| Goldman Sachs Group Inc. | 0.00% | New | 33,900 | $187K |
| BlackRock, Inc. | 0.00% | No change | 30,270 | $167K |
| Connective Capital Management, LLC | 0.15% | Add +3.9% | 29,079 | $161K |
| Citadel Advisors | 0.00% | New | 26,580 | $147K |
| Vestcor Inc | 0.00% | No change | 23,376 | $129K |
| Connecticut Wealth Management, LLC | 0.01% | No change | 22,303 | $123K |
| Renaissance Technologies | 0.00% | Add +50.8% | 20,200 | $112K |
| State Street Corp. | 0.00% | No change | 20,200 | $112K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | No change | 15,554 | $86K |
| Lido Advisors, LLC | 0.00% | Add +1.2% | 14,197 | $78K |
| HRT Financial LP | 0.00% | New | 13,657 | $75K |
| Balyasny Asset Management L.P. | 0.00% | New | 10,804 | $60K |
| Two Sigma Securities, LLC | 0.01% | New | 10,596 | $58K |
| Prudential Financial Inc. | 0.00% | New | 10,000 | $55K |
| Charles Schwab Investment Management Inc. | 0.00% | New | 10,000 | $55K |
| UBS Group AG | 0.00% | Add +30850.0% | 6,809 | $38K |
| Arax Advisory Partners | 0.00% | New | 4,008 | $22K |
| Morgan Stanley | 0.00% | New | 2,361 | $13K |
| Wells Fargo & Company | 0.00% | Add +100000.0% | 1,001 | $6K |
| Citigroup Inc. | 0.00% | New | 958 | $5K |
| Hoertkorn Richard Charles | 0.00% | No change | 668 | $4K |
| Coldstream Capital Management Inc. | 0.00% | New | 150 | $828 |
| Signaturefd, LLC | 0.00% | No change | 100 | $552 |
| Barclays PLC | 0.00% | New | 32 | $177 |
| JPMorgan Chase & Co. | 0.00% | Reduce -12.5% | 21 | $116 |
"% of holder's portfolio" is TLSI's weight in each manager's 13F, not the share of Trisalus Life Sciences Inc. the manager owns.